NEW ORLEANS, April 13, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 4, 2018 to file lead plaintiff applications in a securities class action lawsuit against Longfin Corp. (NasdaqCM:LFIN), if they purchased the Company’s shares between December 15, 2017 and April 2, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Get Help
Longfin investors should visit us at https://www.claimsfiler.com/cases/view-longfin-corp-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Longfin and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On March 26, 2018, Citron Research reported that the Company was “a pure stock scheme” and “[f]ilings and press releases are riddled with inaccuracies and fraud.” Soon thereafter, global index operator FTSE Russell announced that Longfin was being removed from its global indices, less than two weeks after joining. The next day, Longfin CEO Meenavalli stated that the company would file its 10-K within three days; however, no such filing was made by then or during trading on April 2, 2018.
On this event, the price of Longfin’s shares plummeted.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
How Marco Pharma International Preserves German Homeopathic Traditions in America
FTC Questions Apple News Over Alleged Bias Against Conservative Media
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 



